Biolex Forms Broad Strategic Alliance With Centocor

Biolex, a privately held protein therapeutics company, announced a broad-based, multileveled strategic alliance with Centocor, Inc., a leading biopharmaceutical company, to manufacture selected proteins using the Biolex LEX System. The alliance will leverage certain key product candidates in Centocor's therapeutic protein pipeline, using Biolex's innovative method to economically and rapidly both develop and scale-up these proteins. Under the terms of the agreement, Biolex will advance up to 10 Centocor proteins in its patented LEX System. PR Newswire (http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=/www/story/03-21-2005/0003236192&EDATE=)